Salarius Pharmaceuticals's market cap is currently $2.14M. The company's EPS TTM is $-8.193; its P/E ratio is ―; Salarius Pharmaceuticals is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 1.84M	$ 5.23M	$ 3.47M
Gross Profit	$ -10.05K	$ -6.68K	$ 1.82M	$ 5.23M	$ 3.46M
Operating Income	-	$ -31.84M	$ -12.81M	$ -7.79M	$ -9.58M
EBITDA	-	$ -31.60M	$ -12.75M	$ -7.33M	$ -6.92M
Net Income	-	$ -31.37M	$ -12.70M	$ -7.10M	$ -5.61M
Balance Sheet
Cash & Short-Term Investments	$ 5.90M	$ 12.11M	$ 29.21M	$ 11.12M	$ 3.74M
Total Assets	$ 6.59M	$ 14.65M	$ 40.83M	$ 24.93M	$ 13.89M
Total Debt	$ 289.64K	$ 0.00	$ 0.00	$ 477.03K	$ 502.33K
Net Debt	$ -5.61M	$ -12.11M	$ -29.21M	$ -10.64M	$ -3.24M
Total Liabilities	$ 1.30M	$ 4.27M	$ 2.11M	$ 2.77M	$ 3.31M
Stockholders' Equity	$ 5.29M	$ 10.38M	$ 38.72M	$ 22.16M	$ 10.58M
Cash Flow
Free Cash Flow	$ -12.85M	$ -19.10M	$ -10.20M	$ -10.31M	$ -11.58M
Operating Cash Flow	$ -12.85M	$ -17.60M	$ -10.20M	$ -10.31M	$ -11.58M
Investing Cash Flow	$ 0.00	$ -1.50M	$ 0.00	$ -2.60K	$ 5.61M
Financing Cash Flow	$ 6.64M	$ 1.99M	$ 28.30M	$ 17.69M	$ 3.58M

Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

Income Statement >

Salarius Pharmaceuticals Debt to Assets

Balance Sheet >

Salarius Pharmaceuticals Cash Flow

Cash Flow >

Salarius Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing